Mechanism of action
The pharmacodynamics of metoclopramide consists of two complementary components: central and peripheral.
- Central action: The drug readily crosses the blood-brain barrier. In the brain structures, it blocks dopamine ($D_2$) and serotonin ($5-HT_3$) receptors located in the trigger zone of the vomiting center. This is precisely what provides its pronounced antiemetic effect.
- Peripheral (prokinetic) action: At the gastrointestinal tract level, metoclopramide acts as a motility stimulant. It increases the tone of the lower esophageal sphincter, enhances propulsive gastric peristalsis, and simultaneously relaxes the pyloric sphincter. As a result, the evacuation of gastric contents into the duodenum is significantly accelerated.
Indications and contraindications
The drug is administered orally or parenterally (in severe cases). Its primary purpose is to combat dyspeptic disorders and delayed gastric emptying.
Main indications:
- Nausea and vomiting of various origins (including postoperative, occurring after anesthesia, during radiation therapy, or nausea and vomiting of pregnancy).
- Vomiting induced by medications (e.g., cytostatics or cardiac glycosides).
- Symptomatic treatment of acute migraine attacks (for relief of associated vomiting).
Contraindications:
- Mechanical damage to the gastrointestinal tract (perforation, gastrointestinal bleeding).
- Muscle dyskinesia (especially associated with neuroleptic use).
- Breastfeeding period.
Side effects
The adverse reactions of metoclopramide stem directly from its receptor profile and its ability to penetrate the central nervous system.
- Central disorders: Unlike domperidone, which is actively "pumped out" of the brain by the P-glycoprotein transport protein, metoclopramide accumulates in the CNS. Blockade of $D_2$ receptors in the brain can lead to extrapyramidal disorders.
- Endocrine disorders: Blockade of dopamine pathways causes an increase in prolactin levels (hyperprolactinemia), which may manifest as amenorrhea and gynecomastia.
- Gastrointestinal effects: Enhanced motility logically leads to increased stool frequency (diarrhea) and flatulence.
Effect on pharmacokinetics of other drugs
The small intestine is the primary site of absorption for most drug substances. The rate at which chyme leaves the stomach is critical for the bioavailability of other drugs.
Administration of prokinetics, such as metoclopramide, radically accelerates gastric emptying.
- Enhanced absorption: Rapid entry into the intestine leads to intensive absorption of weak bases (e.g., propranolol, codeine).
- Reduced efficacy: For drugs with slow absorption (iron preparations, digoxin), accelerated transit is detrimental. The drug substance simply does not have time to be absorbed, leading to a sharp decrease in its blood concentration and a reduction in the therapeutic effect.
Briefly: answers to topical questions
What are the contraindications for the use of metoclopramide?
Contraindications to the use of metoclopramide include:
- gastrointestinal bleeding;
- gastrointestinal perforation;
- muscle dyskinesia associated with neuroleptic use;
- breastfeeding period.
What specific extrapyramidal disorders can metoclopramide cause?
Sources specifically indicate the development or worsening of parkinsonism for metoclopramide due to penetration across the blood-brain barrier and blockade of dopamine receptors in the CNS. With overdose, extrapyramidal disorders develop rapidly.
Which receptors does metoclopramide interact with peripherally to enhance GI motility?
To enhance gastrointestinal motility, metoclopramide exerts a complex effect on several types of peripheral receptors. It interacts with the following structures:
- D receptors (dopamine) — causes their blockade (anti-dopamine effect).
- 5-HT4 receptors (serotonin) — performs their direct stimulation.
- 5-HT3 receptors (serotonin) — acts as their blocker.
This interaction is localized predominantly in the upper gastrointestinal tract, leading to increased tone of the lower esophageal sphincter, relaxation of the pyloric sphincter, and stimulation of peristalsis.
To memorize the receptor profile: metoclopramide says "Do it Quickly!" — blocks Dopamine and serotonin receptors, accelerating peristalsis.
Class and exam questions
Why does metoclopramide cause extrapyramidal disorders while domperidone does not?
Metoclopramide easily crosses the blood-brain barrier and blocks dopamine receptors in the brain. Domperidone, on the other hand, is a substrate of P-glycoprotein, which performs a protective function and actively pumps the drug back into the bloodstream, preventing it from acting in the CNS.
Why is metoclopramide prescribed as part of complex migraine therapy?
During a migraine attack, severe nausea and vomiting often occur. Metoclopramide is used as symptomatic therapy specifically to relieve these dyspeptic symptoms while other drugs (e.g., triptans) eliminate the pain itself.
How will simultaneous administration of metoclopramide affect digoxin treatment?
Metoclopramide enhances peristalsis and accelerates the passage of chyme through the intestine. Digoxin is absorbed slowly, so with rapid transit, it will not have time to be absorbed in the required volume, leading to a drop in its concentration and treatment failure.
What else to study on this topic
- The role of P-glycoprotein in blood-brain barrier function
- Comparative profile of dopamine receptor blockers
- The effect of GI motility on drug pharmacokinetics
- Strategy of symptomatic and prophylactic migraine therapy
- Central and peripheral effects of antiemetics
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Metoclopramide" and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the «Drugs and Prescriptions» section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.